" class="no-js "lang="en-US"> Casey Imbergamo Archives - Medtech Alert
Tuesday, June 06, 2023

Breaking News

RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings Visgenx Appoints William Pedranti as Chief Executive Officer Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson’s Disease ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting BenevolentAI Progresses BEN-34712 for the Potential Treatment of ALS into IND-Enabling Studies Promontory Therapeutics Announces Preliminary Data from the National Cancer Institute Phase 2 Clinical Trial of PT-112 in Thymoma and Thymic Carcinoma at 2023 ASCO Annual Meeting Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development

Sort by:

Date

Top Post

SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy | MTA

SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy

SNIPR Biome, the company pioneering CRISPR microbial gene therapy, has announced positive interim clinical results […]

Read more

Diseases

 Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers | Pharmtech Focus

Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers

Early results show that a new combination drug therapy is safe and effective against advanced […]

  1. RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings

    Gene Therapy

     Read more
  2. Visgenx Appoints William Pedranti as Chief Executive Officer

    Appointments

     Read more
  3. Airway Therapeutics Completes Enrollment in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

    Clinical Trials

     Read more
  4. The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson’s Disease

    Diseases

     Read more
  5. ITM Announces €255m Investment Round, Plans to Advance Radiopharmaceutical Pipeline and to Expand Radioisotope Production Capacities

    Fundraising

     Read more